Combined prophylactic suppression of graft-versus-host and host-versus-graft reactions following treatment of prospective bone marrow recipients with rat IgG2b anti-mouse T cell antibodies
- 1 April 1986
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 52 (4) , 255-259
- https://doi.org/10.1007/bf00321086
Abstract
A new approach to avoid typical complications from bone marrow transplantation into MHC different mice was studied. Rat monoclonal anti-Thy-1 antibodies of the IgG2b isotype were identified, which inhibit T lymphocytes in vivo so that transplanted donor T cells as well as residual T cells of the conditioned marrow recipient were suppressed. A single injection of these antibodies after irradiation and before marrow transplantation did not only prevent graft-versus-host mortality but suppressed also host-versus-graft reactivity so that the radiation dose necessary for engraftment of donor cells differing in H-2, IA (both haplotypes) major histocompatibility antigens could be reduced to 6.0 Gy. In addition an anti-T leukemic cell effect from the injected monoclonal T cell antibodies was observed.Keywords
This publication has 13 references indexed in Scilit:
- ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)The Lancet, 1984
- DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTSThe Lancet, 1984
- EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASEThe Lancet, 1984
- BONE MARROW REPOPULATION CAPACITY AFTER TRANSPLANTATION OF LYMPHOCYTE-DEPLETED ALLOGENEIC BONE MARROW USING COUNTERFLOW CENTRIFUGATIONTransplantation, 1984
- Allogenic bone marrow transplantation: current status and future directionsBlood, 1983
- Production of Rat Monoclonal Antibodies with the Lou Rat Non Secreting IR983F Myeloma Cell LinePublished by Elsevier ,1982
- BONE MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE EFFECT OF ELIMINATION OF T CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY-1.2 PLUS COMPLEMENT OR ANTIBODY ALONETransplantation, 1981
- ANTILYMPHOCYTIC ANTIBODIES AND MARROW RANSPLANTATIONTransplantation, 1979
- Anti‐lymphocytic antibodies and marrow transplantation. III. Effect of heterologous anti‐brain antibodies on acute secondary disease in miceEuropean Journal of Immunology, 1974
- Suppression of acute secondary disease by heterologous anti-brain serumAnnals of Hematology, 1972